AstraZeneca has asked the FDA to expand the use of its schizophrenia drug Seroquel to treatment of bipolar disorder. Report [1]
AstraZeneca has asked the FDA to expand the use of its schizophrenia drug Seroquel to treatment of bipolar disorder. Report [1]
Links:
[1] http://money.cnn.com/news/newsfeeds/articles/newstex/AFX-0013-21985818.htm